✦ LIBER ✦

Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions

✍ Scribed by O.E. Akilov; C. Grant; R. Frye; S. Bates; R. Piekarz; L.J. Geskin

Book ID: 114707290
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 167
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2012.10905.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose total skin electron beam therap

Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study

✍ M.R. Kamstrup; L.M. Lindahl; R. Gniadecki; L. Iversen; L. Skov; P.M. Petersen; A 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Total Skin Electron Beam Therapy (TSEBT)

Total Skin Electron Beam Therapy (TSEBT) As Palliative Treatment For Cutaneous Manifestations Of Advanced, Therapy-refractory T-cell Lymphoma (CTCL) And Leukemia

✍ Hauswald, S.H.; Zwicker, F.; Debus, J.; Bischof, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Extent of skin involvement as a prognost

Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy

✍ Peter A. Quiros; Barry M. Kacinski; Lynn D. Wilson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

## BACKGROUND. The goal of this study was to define the prognostic significance of the extent of skin involvement (ESI) with respect to disease free survival (DFS) and overall survival (0s) of patients with T3 cutaneous T-cell lymphoma (CTCL) after total skin electron beam therapy (TSEBT). ## MET